Cigna abandons pursuit of Humana, plans $10 billion share buybackReuters Cigna Calls Off Humana Pursuit, Plans Big Stock Buyback – WSJThe Wall Street Journal Cigna Plans $10 Billion Buyback After Ending Humana TalksBloomberg The Cigna Group Announces Significant Increase to Share Repurchase Program of $10 BillionYahoo Finance
Business
Cigna Plans $10 Billion Buyback After Calling Off Humana Talks – Bloomberg
Cigna Plans $10 Billion Buyback After Calling Off Humana TalksBloomberg Cigna Calls Off Humana Pursuit, Plans Big Stock Buyback – WSJThe Wall Street Journal CORRECTED-UPDATE 6-Cigna abandons pursuit of Humana, plans $10 billion share buyback -sourcesYahoo Finance US health insurer Cigna scraps $10B deal to buy Humana: reportNew York Post Listen: Cigna-Humana Off, COP28, MoreBloomberg
Smile Direct Club dentistry aligners firm shuts down – BBC.com
Smile Direct Club dentistry aligners firm shuts downBBC.com Telehealth orthodontics company SmileDirectClub shuts downCNN SmileDirectClub ends operations ‘effective immediately,’ but what about the customers?WGHP FOX8 Greensboro Smile Direct Club shuts down: Nashville based company in bankruptcyTennessean SmileDirectClub shuts down ‘effective immediately,’ leaving customers in limboLiveNOW from FOX
Many Car Dealers Are Getting Nervous About EV Push – The Wall Street Journal
Many Car Dealers Are Getting Nervous About EV PushThe Wall Street Journal A Million Electric Vehicles Were Sold This Year. Here’s Why That’s a Problem.New York Magazine Guest commentary: Why consumer interest in EVs has stalled outAutomotive News U.S. EV Sales Surpass 1 Million Units For The First TimeGM Authority Electric Cars In AmericaDaily Kos
Why FDA approval of sickle cell gene therapy is a ‘big deal’ – PBS NewsHour
Why FDA approval of sickle cell gene therapy is a ‘big deal’PBS NewsHour Triad doctor reacts to FDA approving gene-editing treatment for sickle cell diseaseWXII12 Winston-Salem Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’PBS NewsHour A Sickle Cell Breakthrough Is Here. Now the Hard Part.Bloomberg Crispr: New Sickle Cell […]